Viewing nowAtorvas 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
KMS Pharmaceuticals Co., Ltd.

MFDS item code 201603236 · Approved 2016.06.07 · Insurance code 654701670
Improvement of hyperlipidemia (e.g., hypercholesterolemia); prevention of cardiovascular diseases (e.g., myocardial infarction)
This medication helps reduce the risk of cardiovascular diseases. In particular, it lowers the risk of myocardial infarction and stroke and reduces the chances of requiring angioplasty or experiencing angina. It also decreases the risk of cardiac complications in patients with type 2 diabetes and lowers the hospitalization rate due to congestive heart failure. It is effective in treating hyperlipidemia, lowering total cholesterol, LDL-cholesterol, apolipoprotein B, and triglyceride levels, while raising HDL-cholesterol levels. It is especially beneficial for pediatric patients with a family history or high-risk factors. This medication is used to improve cardiovascular health and manage hyperlipidemia.
Patients receiving atorvastatin should follow a standard cholesterol-lowering diet before and during treatment. This medicine may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is atorvastatin 10 mg once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only for those requiring a reduction in LDL cholesterol of 45 % or more). This medicine is administered at a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and assessing the response. However, if LDL cholesterol levels are unavailable, total cholesterol may be used to monitor response to treatment. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses of this medicine above 20 mg in pediatric patients). The dose should be adjusted appropriately according to the recommended treatment goals for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.
This medication may present muscle-related symptoms, so if muscle pain or weakness worsens significantly or creatine kinase levels elevate greatly, discontinue use immediately and consult a physician. This medication should not be used in patients with severe liver dysfunction, muscle disorders, women who are pregnant or breastfeeding, or patients with certain genetic lactose absorption impairments. Patients with liver or kidney dysfunction, alcoholism, hypothyroidism, elderly individuals, and others at high risk for muscle damage should use this medication cautiously and undergo regular testing. While taking this medication, various side effects such as liver dysfunction, muscle pain, skin rashes, and allergic reactions may occur; if symptoms arise, inform medical personnel immediately. This medication may interact with other drugs, so if you are taking any concomitant medications, be sure to inform your doctor or pharmacist, especially when taken in conjunction with certain antibiotics, antifungals, antivirals, colchicine, and niacin. Women of childbearing potential should use appropriate contraception while taking this medication, and if pregnancy is confirmed, discontinue use immediately. This medication is not recommended for children, particularly those under the age of 10, and long-term safety in adolescents under 18 has not been sufficiently studied. Elderly patients or those with renal impairment are at a higher risk of myopathy and rhabdomyolysis, so they should be carefully observed for any unusual symptoms during treatment. In cases of overdose, there is no specific antidote, so treatment should be symptomatic, and liver function and muscle status should be tested regularly. This medication should be stored out of reach of children and kept in its original packaging to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air and moisture, ideally at room temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the medication's effectiveness over time.
White, round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
KMS Pharmaceuticals Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.